Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Black phosphorus nanoparticles for dual therapy of non-small cell lung cancer.

Journal of drug targeting - 1 Jul 2022

Lin Zhongxiao, Deng Qiudi, Fang Qi, Li Xinzhi, Liu Xiaoyan, Wang Jianglin, Chen Sheng, Huang Xiaotao, Yang Langyu, Miao Yingling, Yu Xi-Yong

Abstract excerpt

Lung cancer remains one of the leading causes of death in humans. Gefitinib is an inhibitor of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) commonly used to suppress tumour growth. However, constantly use of gefitinib results in drug-resistance, reduced efficacy and undesired side effects. To circumvent these drawbacks, targeted and photothermal therapies have emerged as effective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Gefitinib

Share to Nanoparticles

Share to Phosphorus

Share to Protein Kinase Inhibitors

Share to Quinazolines

Source

Identifiers

PMID: 35078385
DOI: 10.1080/1061186X.2022.2032093

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Black phosphorus nanoparticles for dual therapy of non-small cell lung cancer.PMID 35078385Read ↗

Recent progress in drug delivery systems for tyrosine kinase inhibitors in the treatment of lung cancer.Semantic proximity Read ↗

Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer.Semantic proximity Read ↗

Design and Evaluation of EGFR-Targeted Near-Infrared Fluorescent Probes for Selective Tumor Cell ImagingSemantic proximity Read ↗

The Advancement in Magnetic Nanoparticles for the Diagnosis of Lung Cancer and Its MonitoringSemantic proximity Read ↗

Biomedical Applications of Targeted Drug Delivery, Nanotheranostic and Nuclear MedicineSemantic proximity Read ↗

Co-delivery of gefitinib and hematoporphyrin by aptamer-modified fluorinated dendrimer for hypoxia alleviation and enhanced synergistic chemo-photodynamic therapy of NSCLC.Semantic proximity Read ↗

Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid CancerSemantic proximity Read ↗

Hybrid nanovesicles enhance antitumor efficacy in KRAS-mutant non-small cell lung cancer.Semantic proximity Read ↗

Macrophages mediated delivery of chlorin e6 and treatment of lung cancer by photodynamic reprogramming.Semantic proximity Read ↗

CNTs as Excellent Adjuvants for Anticancer Therapeutic Strategies and Cancer Diagnosis: A Plethora of Laboratory Studies versus Few Clinical Trials and Still No Clinical ApplicationSemantic proximity Read ↗

A Recombinant Targeted Bionanoparticle In Vitro Expressing a Gene-Editing Protein for Epidermal Growth Factor Receptor Mutant Lung Cancer.Semantic proximity Read ↗

Biodegradable FePS 3 nanoplatform for efficient treatment of osteosarcoma by combination of gene and NIR-II photothermal therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.